ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.445,91
0,15%
S&P 500
5.473,17
-0,25%
US Dollar vs BRL
5,4537
0,55%
Bitcoin
65.039,67
0,11%
Brent Oil
85,005
0,37%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) Notícias

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BIAF
DataHoraFonteTítuloCódigoCompanhia
12/06/202409:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202410:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
02/05/202409:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
24/04/202409:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
09/04/202409:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
01/04/202410:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202419:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202415:15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202414:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202414:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
06/03/202412:45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202411:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202410:00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
06/02/202410:00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202418:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
30/01/202410:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
23/01/202410:00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
08/01/202410:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
08/12/202318:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
05/12/202310:00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFbioAffinity Technologies Inc
30/11/202310:00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFbioAffinity Technologies Inc
28/11/202310:00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFbioAffinity Technologies Inc
28/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIAFbioAffinity Technologies Inc
16/11/202319:23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIAFbioAffinity Technologies Inc
15/11/202310:00Business WirebioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202318:01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202317:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFbioAffinity Technologies Inc
06/11/202310:00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFbioAffinity Technologies Inc
03/11/202317:49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BIAFbioAffinity Technologies Inc
03/11/202317:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BIAFbioAffinity Technologies Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BIAF

Seu Histórico Recente

BITMOT
987580
Eib Tf 0,95% St37 Eur
BIT
P20PD3
NLBNPIT20PD3 20991231 14...
EU
L581S
L581S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados